OREANDA-NEWS.  GE Capital, Healthcare Financial Services, announced today that it has amended its existing USD 2MM senior secured credit facility to Saladax Biomedical, Inc. to provide an additional USD 8 million multi-draw term loan facility and to modify the terms of the existing USD 2 million term loan. GE Capital, Healthcare Financial Services is acting as administrative agent and sole lender for the credit facility. The loans will be used to provide Saladax with working capital to support ongoing commercialization efforts and for other corporate purposes.

“GE has been our lender for a number of years, so they know our business well and were able to provide us with additional capital at better terms,” said Kevin Harter, CEO of Saladax. "This loan complements our Series D equity raise and allows us to increase our clinical development and commercialization efforts."

“We are pleased to provide financing that will allow Saladax to invest and grow within the personalized medicine field,” said Anthony Storino, senior managing director, GE Capital, Healthcare Financial Services, Life Sciences. “Providing customized financing to support the unique needs of life sciences companies is our team’s specialty.”

Headquartered in Bethlehem, PA, Saladax Biomedical is a leader in the development and deployment of high-quality diagnostic services and products, delivering actionable data to help physicians to select and optimize the use of current and new pharmaceutical products, with the goals of improving health and positively impacting the economics of care.